Depression and Its Comorbid Conditions More Serious in Women than in Men in the United States

Abstract

Background:

Depression is a major public health problem by itself and for its comorbid conditions. We aimed to determine gender differences in the prevalence of depression and how depression is related to comorbid conditions and metabolic biomarkers.

Methods:

This study included men (n=986) and women (n=1,280) aged 20–79 years who were included in the 2007–2010 National Health and Nutrition Examination Survey. Depression was assessed with the Patient Health Questionnaire (PHQ-9). The associations between depression (PHQ-9 score ≥10), self-reported comorbid conditions, and metabolic biomarkers of comorbid conditions were determined by multivariable logistic regressions adjusting for potential confounders.

Results:

The prevalence of depression in men and women were 7.9% and 12.1%, respectively (p<0.01). The odds ratios (OR) of various comorbid conditions (asthma, arthritis, gout, coronary heart disease, heart attack, stroke, diabetes mellitus, thyroid problem, and metabolic syndrome) by the status of depression were significantly higher in women. High C-reactive protein (CRP) was a significant predictor of depression in men (OR 2.02, 95% confidence interval [CI] 1.11–3.67) in unadjusted model. In women, high fasting blood glucose, high glycohemoglobin, and high CRP were significant predictors of depression (OR 1.20, 95% CI 1.28–3.01; OR 2.44, 95% CI 1.21–4.92; OR 1.44, 95% CI 1.01–2.06; OR 1.79, 95% CI 0.19–2.67, respectively) after controlling for age, education, race/ethnicity, marital status, ratio of family income to poverty, and physical activity.

Conclusions:

Women had higher prevalence of depression and higher number of significant associations between socioeconomic status, comorbid conditions, and metabolic risk factors by the status of depression than men. Public health attentions are needed to improve women's mental health.

Get full access to this article

View all access options for this article.

References

Mathers

, Loncar

. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 2006; 3:2011–2030.

World Federation for Mental Health. Depression: A global crisis. World Federation for Mental Health, 2012.

Ferrari

, Charlson

, Norman

, et al. The epidemiological modelling of major depressive disorder: Application for the Global Burden of Disease Study 2010. PLoS One, 2013; 8:e69637.

Centers for Disease Control and Prevention. Current depression among adults-United States, 2006 and 2008. MMWR Morb Mortal Wkly Rep, 2010; 59:1229–1235.

Topic

, Milicic

, Stimac

, et al. Somatic comorbidity, metabolic syndrome, cardiovascular risk, and CRP in patients with recurrent depressive disorders. Croat Med J, 2013; 54:453–459.

World Health Organization (WHO). Comprehensive mental health action plan 2013–2020. WHO, 2013. Available at www.who.int/mental_health/action_plan_2013/en Accessed Mar 27, 2014 .

Herva

, Rasanen

, Miettunen

, et al. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: The Northern Finland 1966 Birth Cohort Study. Psychosom Med, 2006; 68:213–216.

Kinder

, Carnethon

, Palaniappan

, et al. Depression and the metabolic syndrome in young adults: Findings from the Third National Health and Nutrition Examination Survey. Psychosom Med, 2004; 66:316–322.

Dunbar

, Reddy

, Davis-Lameloise

, et al. Depression: An important comorbidity with metabolic syndrome in a general population. Diabetes Care, 2008; 31:2368–2373.

10.

United States Centers for Disease Control and Prevention (CDC). Analytic note regarding 2007–2010 Survey design changes and combining data across other survey cycles. CDC, 2011. Available at www.cdc.gov/nchs/data/nhanes/analyticnote_2007–2010.pdf Accessed Aug 25, 2014 .

11.

Kroenke

, Spitzer

, Williams

. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med, 2001; 16:606–613.

12.

World Heath Organization. Obesity: Preventing and managing the global epidemic. Geneva, Switzerland: World Health Organization, 2000.

13.

Matthews

, Hosker

, Rudenski

, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28:412–419.

14.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285:2486–2497.

15.

Ascaso

, Pardo

, Real

, et al. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care, 2003; 26:3320–3325.

16.

Executive summary: Standards of medical care in diabetes—2010. Diabetes Care, 2010; 33:S4–10.

17.

Ridker

. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 2003; 107:363–369.

18.

U.S. Department of Health and Human Services (DHHS). Poverty guidelines, research, and measurement. Washington, DC: US DHHS, 2013. Available at: http://aspe.hhs.gov/poverty/13poverty.cfm Accessed March 26, 2014 .

19.

Grimm

, Foltz

, Blanck

, et al. Household income disparities in fruit and vegetable consumption by state and territory: Results of the 2009 Behavioral Risk Factor Surveillance System. J Acad Nutr Diet, 2012; 112:2014–2021.

20.

Tucker

, Welk

, Beyler

. Physical activity in U.S.: Adults compliance with the Physical Activity Guidelines for Americans. Am J Prev Med, 2011; 40:454–461.

21.

Loerbroks

, Herr

, Subramanian

, et al. The association of asthma and wheezing with major depressive episodes: An analysis of 245 727 women and men from 57 countries. Int J Epidemiol, 2012; 41:1436–1444.

22.

Matcham

, Rayner

, Steer

, et al. The prevalence of depression in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatology (Oxford), 2013; 52:2136–2148.

23.

Nicholson

, Kuper

, Hemingway

. Depression as an aetiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J, 2006; 27:2763–2774.

24.

van Melle

, de Jonge

, Kuyper

, et al. Prediction of depressive disorder following myocardial infarction data from the Myocardial INfarction and Depression-Intervention Trial (MIND-IT). Int J Cardiol, 2006; 109:88–94.

25.

Andrade

, Caraveo-Anduaga

, Berglund

, et al. The epidemiology of major depressive episodes: Results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res, 2003; 12:3–21.

26.

Rudisch

, Nemeroff

. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry, 2003; 54:227–240.

27.

Mezuk

, Eaton

, Albrecht

, et al. Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care, 2008; 31:2383–2390.

28.

Ljubicic

, Jakovac

, Bistrovic

, et al. Prevalence of metabolic syndrome among patients with major depressive disorder—Differences between newly diagnosed first episode and recurrent disease. Coll Antropol, 2013; 37:1065–1069.

29.

Toker

, Shirom

, Melamed

. Depression and the metabolic syndrome: Gender-dependent associations. Depress Anxiety, 2008; 25:661–669.

30.

Cooper

, Trivedi

, Nelson

, et al. Sex differences in associations of depressive symptoms with cardiovascular risk factors and metabolic syndrome among African Americans. Cardiovasc Psychiatry Neurol, 2013; 2013:979185.

31.

Chan

, Inouye

, Riddell

, et al. Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinol, 2003; 28:87–102.

32.

Cameron

, Kronfol

, Greden

, et al. Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. Arch Gen Psychiatry, 1984; 41:1090–1095.

33.

Dantzer

, O'Connor

, Freund

, et al. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci, 2008; 9:46–56.

34.

Smith

, Vale

. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci, 2006; 8:383–395.

35.

Wright

, Jacisin

, Radin

, et al. Glucose metabolism in unipolar depression. Br J Psychiatry, 1978; 132:386–393.

36.

Anderson

, Freedland

, Clouse

, et al. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care, 2001; 24:1069–1078.

37.

Howren

, Lamkin

, Suls

. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosom Med, 2009; 71:171–186.

38.

azze

, Lucido

, Shamoon

. Psychological and social correlates of glycemic control. Diabetes Care, 1984; 7(4):360–366.

39.

Okamura

, Tashiro

, Utumi

, et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: Minimal model analysis. Metabolism, 2000; 49:1255–1260.